Your session is about to expire
← Back to Search
Hemostatic Dressing
QuikClot Control+ for Hemostasis
N/A
Waitlist Available
Led By Mumashir Mumtaz, MD
Research Sponsored by Z-Medica
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 minute and 10 minutes
Awards & highlights
Summary
This trial is testing whether QuikClot Control+ is effective at controlling internal organ space bleeding for patients displaying Class III or Class IV Bleeding.
Eligible Conditions
- Hemostasis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 minute and 10 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 minute and 10 minutes
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Achievement of hemostasis
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: QuikClot Control+Experimental Treatment1 Intervention
QuikClot Control+
Group II: Standard gauzePlacebo Group1 Intervention
Standard gauze per standard of care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
QuikClot Control+
2020
N/A
~270
Find a Location
Who is running the clinical trial?
Z-MedicaLead Sponsor
1 Previous Clinical Trials
300 Total Patients Enrolled
Mumashir Mumtaz, MDPrincipal InvestigatorUPMC Pinnacle
Share this study with friends
Copy Link
Messenger